This work was produced by James et al. under the terms of a commissioning contract issued by the Secretary of State for Health and Social Care. This is an Open Access publication distributed under the terms of the Creative Commons Attribution CC BY 4.0 licence, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. See: https://creativecommons.org/licenses/by/4.0/. For attribution the title, original author(s), the publication source – NIHR Journals Library, and the DOI of the publication must be cited.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
James N, Pirrie S, Liu W, et al. Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT. Southampton (UK): National Institute for Health and Care Research; 2024 Aug. (Health Technology Assessment, No. 28.42.)
Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT.
Show details- AE
adverse event
- BAUS
British Association of Urological Surgeons
- BC
bladder cancer
- BCG
Bacillus Calmette–Guerin
- CIS
carcinoma in situ
- CTE
Commissioning through Evaluation
- CONSORT
Consolidated Standards of Reporting Trials
- cp
cell pellet
- CRCTU
Cancer Research Clinical Trials Unit
- CTE
Commissioning through Evaluation
- DMC
Data Monitoring Committee
- DTT
decision to treat
- EAU
European Association of Urology
- eGFR
estimated glomerular filtration rate
- FBC
full blood count
- GCP
good clinical practice
- HBRC
Human Biomaterials Resource Centre
- HTA
Health Technology Assessment
- ISRCTN
International Standard Randomised Controlled Trial Number
- LFT
liver function test
- MDT
multidisciplinary team
- MIBC
muscle-invasive bladder cancer
- mpMRI
multiparametric magnetic resonance imaging
- MRI
magnetic resonance imaging
- NIHR
National Institute for Health and Care Research
- NMIBC
non-muscle-invasive bladder cancer
- REC
Research Ethics Committee
- SOC
standard of care
- TMG
Trial Management Group
- TSC
Trial Steering Committee
- TTCT
time to correct treatment
- TTDT
time to definitive treatment
- TURBT
transurethral resection of bladder tumour
- UCC
urothelial cell carcinoma
- VI-RADS
Vesical Imaging-Reporting and Data System
- WHO
World Health Organization
- List of abbreviations - Image directed redesign of bladder cancer treatment path...List of abbreviations - Image directed redesign of bladder cancer treatment pathways: the BladderPath RCT
- PREDICTED: Homo sapiens SSX family member 2 interacting protein (SSX2IP), transc...PREDICTED: Homo sapiens SSX family member 2 interacting protein (SSX2IP), transcript variant X2, mRNAgi|2217263723|ref|XM_017000234.3|Nucleotide
- Homo sapiens cDNA FLJ76842 complete cds, highly similar to Homo sapiens v-fos FB...Homo sapiens cDNA FLJ76842 complete cds, highly similar to Homo sapiens v-fos FBJ murine osteosarcoma viral oncogene homolog (FOS), mRNAgi|158256087|dbj|AK291326.1|Nucleotide
- Chiasmodon niger voucher CHN005 cytochrome oxidase subunit 1 (COI) gene, partial...Chiasmodon niger voucher CHN005 cytochrome oxidase subunit 1 (COI) gene, partial cds; mitochondrialgi|2496522530|gnl|uoguelph|CHIAS005 OI-5P|gb|ON341015.1|Nucleotide
- Chiasmodon niger isolate EN627_MWT1_40 cytochrome c oxidase subunit I (COX1) gen...Chiasmodon niger isolate EN627_MWT1_40 cytochrome c oxidase subunit I (COX1) gene, partial cds; mitochondrialgi|2496529544|gb|OQ870403.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...